The global saliva collection & diagnostics market was estimated at USD 1,645.2 million in 2021 and it is expected to surpass around USD 5514.02 million by 2030, poised to grow at a CAGR of 11.4% from 2022 to 2030.
An extensive rise in disease research studies along with a growing number of new product launches is expected to leverage the market during the forecast period. For instance, in June 2021, Naveris, Inc. announced the launch of its new saliva-based test which is capable to detect neck and head cancer.
The salivary analysis offers reliable inferences in research on diseases such as viral infections, bacterial infections, oncology, toxicology, forensics, autoimmune diseases and endocrinology. In addition, the gradual rise in the use of oral fluid samples for diagnostic & research applications, rising emphasis on non-invasive sample collection procedures, and positive approach of patients to this type of sample collection is also estimated to drive the market growth during the forecast period. For instance, in August 2022, according to a study conducted by a group of researchers in Israel, saliva samples can be utilized for the diagnosis of PTSD (post-traumatic stress disorder).
U.S. Food and Drug Administration (FDA) recommended a saliva-direct COVID-19 diagnostic test as a new and efficient diagnostic method over nasopharyngeal swab method to diagnose COVID-19 infection to make up for the short supply of COVID-19 diagnostic reagents. This situation heavily boosted the market during the pandemic situation.
Moreover, diagnostic technological advancements in cases of infant saliva collection are also anticipated to drive market growth during the forecast period. For instance, the kits developed by Oasis Diagnostics for infants facilitate sample collection with a simple design by being able to mesmerize infants during the procedure.
An increase in the number of ailments, number of clinical trials are rising the need for the growth of the saliva collection devices market. The utility rate of point-of-care test kits is on the rise due to mandated testing of forensics, drug abuse testing for employees, driving staff, and the population at risk of occupational hazards. For instance, in April 2022, a group of researchers developed a saliva test for the detection of glaucoma in high-risk individuals.
Scope of The Report
|Market Size in 2021||USD 1,645.2 million
|Revenue Forecast by 2030||USD 5514.02 million|
|Growth rate from 2022 to 2030||CAGR of 11.4%
|Forecast Period||2022 to 2030|
|Segmentation||Saliva Type, Application, End use, Region
OraSure Technologies, Draeger, Securetec Detektions-Systeme, Oranoxis, Lin-Zhi International, Oasis Diagnostics, Cell Projects, Prometheus bio, Quest Diagnostics, Abbott Laboratories, Premier Biotech, Neogen Corporation, Guangzhou Wondfo Biotech, Salimetrics.
Neuro-navigation Systems Market (By Product Type: Optical System, Electromagnetic System; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Forensic Genomics Market (By Solution: Kits, Analyzers & Sequencers, Software, Consumables; By Method; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Personalized Medicine Biomarkers Market (By Technology: Liquid Biopsy; By Application: Oncology, Cardiology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
3D Printed Prosthetics Market (By Product Type: Sockets, Limbs, Joints, Covers; By Material; By End-Use)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Vulvovaginal Candidiasis Treatment Market (By Drug Type: Clotrimazole, Nystatin, Fluconazole; By Route Of Administration; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...